{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:36:52Z","timestamp":1785731812489,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jaad.2018.11.026","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T05:35:45Z","timestamp":1542864945000},"page":"1168-1171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Time to reconsider the role of sentinel lymph node biopsy in melanoma"],"prefix":"10.1016","volume":"80","author":[{"given":"Michael","family":"Bigby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Zagarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sladden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalin M.","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.11.026_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.11.026_bib2","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.11.026_bib3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bjd.13675","article-title":"No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report","volume":"172","author":"Sladden","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.11.026_bib4","unstructured":"Coit D. Natural history of patients with a positive sentinel node followed with active surveillance. 9th World Congress of Melanoma. Brisbane, Australia. October 2017."},{"key":"10.1016\/j.jaad.2018.11.026_bib5","first-page":"6","article-title":"How long will sentinel node biopsy remain standard in melanoma?","volume":"33","author":"Jacques-Grob","year":"2015","journal-title":"Melanoma Lett"},{"key":"10.1016\/j.jaad.2018.11.026_bib6","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1056\/NEJMe1704290","article-title":"The enigma of regional lymph nodes in melanoma","volume":"376","author":"Coit","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.11.026_bib7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2018.11.026_bib8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.11.026_bib9","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/dsu.12351","article-title":"Prognostic value of sentinel lymph node biopsy compared with that of Breslow thickness: implications for informed consent in patients with invasive melanoma","volume":"39","author":"Freeman","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2018.11.026_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/ajd.12732","article-title":"Sentinel lymph node biopsy status is not the most powerful predictor of prognosis in cutaneous melanoma","volume":"58","author":"Zagarella","year":"2017","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2018.11.026_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ad.2014.10.009","article-title":"Cost analysis of sentinel lymph node biopsy in melanoma","volume":"106","author":"Mart\u00ednez-Mench\u00f3n","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2018.11.026_bib12","author":"Coliron"},{"key":"10.1016\/j.jaad.2018.11.026_bib13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.bjc.6605849","article-title":"Melanoma sentinel node biopsy and prediction models for relapse and overall survival","volume":"103","author":"Mitra","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2018.11.026_bib15","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.11.026_bib16","doi-asserted-by":"crossref","first-page":"h5940","DOI":"10.1136\/bmj.h5940","article-title":"Sentinel lymph node biopsy in melanoma","volume":"351","author":"Bigby","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2018.11.026_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1056\/NEJMc1716071","article-title":"Adjuvant therapy in resected melanoma","volume":"378","author":"Sladden","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.11.026_bib18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bjd.13666","article-title":"Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice","volume":"172","author":"McGregor","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.11.026_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ncponc1014","article-title":"Prognostic false-positivity of the sentinel node in melanoma","volume":"5","author":"Meirion Thomas","year":"2008","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jaad.2018.11.026_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1245\/s10434-016-5458-y","article-title":"outcome of melanoma patients who did not proceed to sentinel node biopsy after preoperative lymphoscintigraphy","volume":"24","author":"Ipenburg","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2018.11.026_bib21","series-title":"Human Inference: Strategies and Shortcomings of Social Judgment","first-page":"330","author":"Nisbett","year":"1980"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218329529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218329529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:48:10Z","timestamp":1759272490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218329529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0190962218329529"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.11.026","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time to reconsider the role of sentinel lymph node biopsy in melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}